IRCT20220209053979N6已完成未知
Bioequivalence Study of Escitalopram 10 mg of Pars Darou and Cipralex manufactured by Lundbeck in 24 Healthy Volunteers
Pars Darou Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Laboratory tests +/- 10% of normal interval
- •Without any history of chronic sickness
排除标准
- •History of medicine consumption
- •Donation of blood sample more than 300 ml within last 30 days
研究者
相似试验
已完成
4 期
Bioequivalence Study of 10 mg Escitalopram Oxalate Film Coated Tablets in Healthy VolunteersHealthy volunteersTCTR20161025003Medifive Pharma Co., Ltd.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Escitalopram 20 mg F.C. Tablet formulations.IRCT20180620040164N44Karen Pharma and Food Supplement Co.24
尚未招募
不适用
Comparative in vivo evaluation of 2 Escitalopram 20 mg F.C. Tablet formulations.Mood disorder due to known physiological condition with major depressive-like episode.Mood disorder due to known physiological condition with major depressive-like episodeF06.32IRCT20180620040164N39Actover Pharmaceutical Co.24
已完成
2 期
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
招募中
3 期
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80